Internal Medicine · Fountain Valley, CA
NPI
1225244775
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
9900 Talbert Ave Ste 103a
Fountain Valley, CA, 92708
Phone (714) 783-1838
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.6M
141,089 services
Medicare patients, 2024
648
Average age 76
Drug cost, 2024
$8.2M
1,776 prescriptions
Company payments, 2025
$3,468
From 43 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Collin C Vu was code J9263 (injection, oxaliplatin, 0.5 mg), 19,400 times for 14 patients. In total Collin C Vu billed 141,089 services in 99 codes, and Medicare paid $2.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 19,400 | 14 | $0.06 | $1,075 |
| J0897 Injection, denosumab, 1 mg | Office | 5,940 | 16 | $20.69 | $123K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,532 | 37 | $0.09 | $409 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,776 | 27 | $0.07 | $131 |
| J1642 Injection, heparin sodium, (heparin lock flush), per 10 units | Office | 1,500 | 13 | $0.01 | $16.03 |
| 99214 Office E&M - Established | Office | 1,316 | 346 | $102.84 | $135K |
| 99232 Hospital E&M - Subsequent | Facility | 1,107 | 232 | $64.87 | $72K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 632 | 11 | $3.56 | $2,251 |
| J9190 Injection, fluorouracil, 500 mg | Office | 515 | 12 | $2.37 | $1,222 |
| 96372 Injection Administration | Office | 477 | 64 | $12.32 | $5,877 |
| 96367 Intravenous Infusion, Hydration | Office | 418 | 40 | $25.35 | $11K |
| 96413 Chemotherapy Administration | Office | 353 | 44 | $117.81 | $42K |
| 99223 Hospital E&M - Initial | Facility | 268 | 218 | $142.61 | $38K |
| 96417 Chemotherapy Administration | Office | 224 | 31 | $57.73 | $13K |
| 99213 Office E&M - Established | Office | 221 | 119 | $65.97 | $15K |
By year: 2022 $1.9M for 137,845 services; 2023 $2.4M for 121,922 services; 2024 $2.6M for 141,089 services.
Medicare prescription drug claims, 2024
In 2024, the drug Collin C Vu prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 103 prescriptions and refills. In total Collin C Vu wrote 1,776 Medicare prescriptions that cost $8.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Procrit Epoetin Alfa | 103 | 104 | 31 | $219K |
| Exemestane Generic | 103 | 204 | 34 | $34K |
| Zarxio Filgrastim-Sndz | 55 | 55 | 19 | $73K |
| Lupron Depot Leuprolide Acetate | 53 | 159 | 21 | $298K |
| Dexamethasone Sodium Phosphate Generic | 52 | 52 | 17 | $257 |
| Xgeva Denosumab | 52 | 52 | Under 11 | $166K |
| Prednisone Generic | 49 | 49 | 19 | $180 |
| Tagrisso Osimertinib Mesylate | 48 | 48 | 11 | $812K |
| Dexamethasone Generic | 48 | 53 | 17 | $803 |
| Ondansetron Hcl Ondansetron Hcl/Pf | 42 | 42 | 14 | $70.7 |
| Famotidine Famotidine/Pf | 40 | 40 | Under 11 | $60.37 |
| Diphenhydramine Hcl Generic | 40 | 40 | Under 11 | $103 |
| Keytruda Pembrolizumab | 39 | 39 | Under 11 | $435K |
| Palonosetron Hcl Generic | 37 | 37 | Under 11 | $1,325 |
| Verzenio Abemaciclib | 36 | 36 | Under 11 | $546K |
Brand drugs: - claims; generic drugs: 937 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Collin C Vu $3,468 ($3,468 in general payments such as food, travel and fees) from 43 companies. The largest payer was Novartis Pharmaceuticals Corporation with $286.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 12 | $286 |
| Merck Sharp & Dohme LLC MRK | 9 | $272 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $259 |
| Pfizer Inc. PFE | 9 | $229 |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $196 |
| Janssen Biotech, Inc. JNJ | 9 | $177 |
| Daiichi Sankyo Inc. 4568.T | 7 | $173 |
| Genentech USA, Inc. ROG.SW | 5 | $158 |
| Eisai Inc. 4523.T | 5 | $129 |
| Abbvie Inc. ABBV | 5 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.